Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 2/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | HTR1D | P28221 | 2/20 | 0.36 |
| ▸ | HTR1B | P28222 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9759493 | 1.00 | CHRM3 (0.40) | CHRM3CHRM2CHRM1HTR1DHTR1B | |
| SCHEMBL9759554 | 0.83 | HTR1A (0.56) | HTR1DHTR1B | |
| SCHEMBL9759555 | 0.83 | HTR1A (0.56) | HTR1DHTR1B | |
| SCHEMBL9759589 | 0.73 | HTR1A (0.55) | HTR1DHTR1B | |
| SCHEMBL9759593 | 0.73 | HTR1A (0.55) | HTR1DHTR1B | |
| SCHEMBL8076509 | 0.72 | CHRM3 (0.70) | CHRM3CHRM2CHRM1HTR1DHTR1B | |
| SCHEMBL6542148 | 0.72 | CHRM3 (0.61) | CHRM3CHRM2CHRM1HTR1DHTR1B | |
| SCHEMBL9759359 | 0.69 | HTR1A (0.55) | HTR1DHTR1B | |
| SCHEMBL9759351 | 0.69 | HTR1A (0.55) | HTR1DHTR1B | |
| Hydrochloric Acid SCHEMBL9359964 | 0.67 | CHRM3 (0.42) | CHRM3CHRM2CHRM1HTR1DHTR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5047422-A | Treating A Disorder Of The Central Nervous System, Cardiovascular System Or Intestinal Tract | BAYER AKTIENGESELLSCHAFT (DE) | 1991-09-10 | — | — | US | disclosed |
| US-4968679-A | DISORDERS OF CENTRAL NERVOUS SYSTEM, CARDIOVASCULAR SYSTEM OR INTESTINAL TRACT | BAYER AKTIENGESELLSCHAFT (DE) | 1990-11-06 | — | — | US | disclosed |
| US-4873262-A | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, CARDIIOVASCULAR SYSTEM OR INTESTINAL TRACT | BAYER AKTIENGESELLSCHAFT (DE) | 1989-10-10 | — | — | US | disclosed |